Insider Transactions Reported by 10 Insiders of Nuvectis Pharma, Inc.

Symbol: NVCT on Nasdaq
Location: Fort Lee, NJ

Quick Takeaways

NVCT - Nuvectis Pharma, Inc. has 10 insiders with reported activity on this page.
Net insider value flow over the last year: +$1,858,421.
Recent transaction rows are available for direct filing-level review.

What Changed

Buy value: $1,858,421; sell value: $0.
Net share flow: +271,644.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to buying over the last 12 months. Net value: +$1,858,421.

Buys

$1,858,421

Shares: 271,644

Insiders: 4

Sells

Shares: 0

Insiders: 0

Net

+$1,858,421

Shares: +271,644

Insiders: 4

Window (months)	Buy shares	Buy $	Sell $	Net $
0-3	0	$0	$0	$0
3-6	29,000	$168,110	$0	+$168,110
6-9	154,770	$957,083	$0	+$957,083
9-12	87,874	$733,227	$0	+$733,227

Nuvectis Pharma, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
Ron Bentsur	Chairman & CEO, Director, 10%+ Owner	$27,752,858	+$28,600	+0.1%	Mixed	06 Jan 2026
Marlio Charles Mosseri	10%+ Owner	$20,355,809	+$1,690,311	+9.1%	Mixed	23 Oct 2025
Enrique Poradosu	Chief Science & Business Off	$13,637,527			Mixed	06 Jan 2026
Shay Shemesh	Chief Dev. & Ops. Officer	$13,537,484			Mixed	06 Jan 2026
Michael J. Carson	Vice President, Finance	$1,510,870			Mixed	06 Jan 2026
Kenneth Hoberman	Director	$1,122,370			Mixed	12 Jun 2025
James F. Oliviero III	Director	$740,390			Mixed	12 Jun 2025
Matthew L. Kaplan	Director	$728,598	+$64,240	+9.7%	Filing P/S	05 Nov 2025
Juan Sanchez	Director	$454,986	+$75,270	+20%	Mixed	05 Nov 2025
Uri Ben-Or	Int. Principal Financial Off.	$283,471			Mixed	08 Feb 2022

Top shareholders of Nuvectis Pharma, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Ron Bentsur	3/4/5	Chairman & CEO, Director, 10%+ Owner	— class O/S missing	3,675,924	$27,752,858	+$28,600	06 Jan 2026	3/4/5
Marlio Charles Mosseri	3/4/5	10%+ Owner	— class O/S missing	3,245,897	$20,355,809	+$1,690,311	23 Oct 2025	3/4/5
Enrique Poradosu	3/4/5	Chief Science & Business Off	— class O/S missing	1,806,319	$13,637,527	—	06 Jan 2026	3/4/5
Shay Shemesh	3/4/5	Chief Dev. & Ops. Officer	— class O/S missing	1,793,068	$13,537,484	—	06 Jan 2026	3/4/5
VANGUARD GROUP INC	13F	Company	— class O/S missing	845,502	$6,383,541	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	— class O/S missing	782,805	$5,910,179	—	31 Dec 2025	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	— class O/S missing	586,320	$4,426,716	—	31 Dec 2025	13F
BALDWIN WEALTH PARTNERS LLC/MA	13F	Company	— class O/S missing	389,625	$2,941,669	—	31 Dec 2025	13F
Occam Crest Management LP	13F	Company	— class O/S missing	380,000	$2,869,000	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	364,024	$2,748,937	—	31 Dec 2025	13F
Michael J. Carson	3/4/5	Vice President, Finance	— class O/S missing	200,118	$1,510,870	—	06 Jan 2026	3/4/5
STATE STREET CORP	13F	Company	— class O/S missing	154,666	$1,167,728	—	31 Dec 2025	13F
Kenneth Hoberman	3/4/5	Director	— class O/S missing	133,140	$1,122,370	—	12 Jun 2025	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	134,154	$1,012,863	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	116,405	$878,857	—	31 Dec 2025	13F
James F. Oliviero III	3/4/5	Director	— class O/S missing	87,828	$740,390	—	12 Jun 2025	3/4/5
Matthew L. Kaplan	3/4/5	Director	— class O/S missing	124,760	$728,598	+$64,240	05 Nov 2025	3/4/5
OPPENHEIMER & CO INC	13F	Company	— class O/S missing	73,566	$555,423	—	31 Dec 2025	13F
Juan Sanchez	3/4/5	Director	— class O/S missing	78,565	$454,986	+$75,270	05 Nov 2025	3/4/5
FORBES J M & CO LLP	13F	Company	— class O/S missing	59,000	$445,450	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— class O/S missing	44,022	$332,366	—	31 Dec 2025	13F
Uri Ben-Or	3/4/5	Int. Principal Financial Off.	— class O/S missing	25,584	$283,471	—	08 Feb 2022	3/4/5
Bank of New York Mellon Corp	13F	Company	— class O/S missing	31,635	$238,847	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	— class O/S missing	28,011	$211,484	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	26,503	$200,098	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	— class O/S missing	24,185	$182,596	—	31 Dec 2025	13F
Austin Wealth Management, LLC	13F	Company	— class O/S missing	20,125	$178,106	—	31 Dec 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	16,929	$127,814	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	— class O/S missing	16,749	$126,455	—	31 Dec 2025	13F
EDMOND DE ROTHSCHILD HOLDING S.A.	13F	Company	— class O/S missing	15,170	$114,534	—	31 Dec 2025	13F
CIBC Private Wealth Group LLC	13F	Company	— class O/S missing	14,574	$110,034	—	31 Dec 2025	13F
Avalon Trust Co	13F	Company	— class O/S missing	14,000	$105,700	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	13,470	$101,699	—	31 Dec 2025	13F
NATIONS FINANCIAL GROUP INC, /IA/ /ADV	13F	Company	— class O/S missing	13,000	$98,150	—	31 Dec 2025	13F
DEUTSCHE BANK AG\	13F	Company	— class O/S missing	12,672	$95,674	—	31 Dec 2025	13F
RHUMBLINE ADVISERS	13F	Company	— class O/S missing	8,433	$63,665	—	31 Dec 2025	13F
UBS Group AG	13F	Company	— class O/S missing	8,375	$63,231	—	31 Dec 2025	13F
FMR LLC	13F	Company	— class O/S missing	7,210	$54,436	—	31 Dec 2025	13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13F	Company	— class O/S missing	7,198	$54,345	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	6,382	$48,185	—	31 Dec 2025	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	— class O/S missing	5,000	$37,750	—	31 Dec 2025	13F
Police & Firemen's Retirement System of New Jersey	13F	Company	— class O/S missing	3,785	$28,577	—	31 Dec 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	— class O/S missing	3,541	$26,735	—	31 Dec 2025	13F
NBC SECURITIES, INC.	13F	Company	— class O/S missing	3,000	$22,650	—	31 Dec 2025	13F
Legal & General Group Plc	13F	Company	— class O/S missing	1,434	$10,827	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	1,418	$10,706	—	31 Dec 2025	13F
Ameritas Investment Partners, Inc.	13F	Company	— class O/S missing	1,314	$9,921	—	31 Dec 2025	13F
Russell Investments Group, Ltd.	13F	Company	— class O/S missing	1,066	$8,048	—	31 Dec 2025	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	— class O/S missing	953	$7,195	—	31 Dec 2025	13F
ROYAL BANK OF CANADA	13F	Company	— class O/S missing	922	$7,000	—	31 Dec 2025	13F

Recent Insider Transactions by Companies or Individuals for Nuvectis Pharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Shay Shemesh	NVCT	Common Stock	Award	9.13%			150,000	1,793,068	06 Jan 2026	Direct
Ron Bentsur	NVCT	Common Stock	Award	4.25%			150,000	3,675,924	06 Jan 2026	Direct
Enrique Poradosu	NVCT	Common Stock	Award	9.06%			150,000	1,806,319	06 Jan 2026	Direct
Michael J. Carson	NVCT	Common Stock	Award	44%			61,200	200,118	06 Jan 2026	Direct
Juan Sanchez	NVCT	Common Stock	Purchase	20%	$75,270	$5.79	13,000	78,150	05 Nov 2025	Direct
Matthew L. Kaplan	NVCT	Common Stock	Purchase	9.67%	$64,240	$5.84	11,000	124,760	05 Nov 2025	Direct
Ron Bentsur	NVCT	Common Stock	Purchase	0.14%	$28,600	$5.72	5,000	3,525,924	05 Nov 2025	Direct
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	2.38%	$457,410	$6.28	72,836	3,136,576	27 Oct 2025	By Emerald Hill Ventures SARL SPF.
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	1.16%	$215,459	$6.15	35,034	3,063,740	24 Oct 2025	By Emerald Hill Ventures SARL SPF.
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	1.57%	$284,214	$6.06	46,900	3,028,706	23 Oct 2025	By Emerald Hill Ventures SARL SPF.
Juan Sanchez	NVCT	Common Stock	Award	85.4%			30,000	65,150	22 Sep 2025	Direct
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	0.19%	$44,768	$7.99	5,603	2,981,806	20 Jun 2025	By Emerald Hill Ventures SARL SPF.
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	0.95%	$225,746	$8.05	28,043	2,976,203	18 Jun 2025	By Emerald Hill Ventures SARL SPF.
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	0.18%	$43,786	$8.11	5,399	2,948,160	17 Jun 2025	By Emerald Hill Ventures SARL SPF.
Matthew L. Kaplan	NVCT	Common Stock	Award	35.8%			30,000	113,760	12 Jun 2025	Direct
James F. Oliviero III	NVCT	Common Stock	Award	51.9%			30,000	87,828	12 Jun 2025	Direct
Kenneth Hoberman	NVCT	Common Stock	Award	29.1%			30,000	133,140	12 Jun 2025	Direct
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	0.72%	$171,664	$8.11	21,167	2,942,761	12 May 2025	By Emerald Hill Ventures SARL SPF.
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	0.86%	$223,965	$8.94	25,062	2,936,594	09 May 2025	By Emerald Hill Ventures SARL SPF.
Marlio Charles Mosseri	NVCT	Common Stock	Purchase	0.09%	$23,298	$8.96	2,600	2,911,532	08 May 2025	By Emerald Hill Ventures SARL SPF.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.